• Something wrong with this record ?

Refractory celiac disease new diagnostic approaches and current treatment

Michael Schumann, Christian Bojarski, Verena Moos, Severin Daum

. 2014 ; 2 (1) : 33-37.

Language English Country United States

Persistent link   https://www.medvik.cz/link/bmc15025257

Since refractory celiac disease (RCD) may cause severe complications and is associated with a poor prognosis in a portion of patients, early diagnosis and treatment is of importance. Current diagnostics include complex PCR-based molecular pathology and FACS techniques in order to differentiate type I and type II RCD, the latter being associated with the development of an enteropathy-associated T cell lymphoma (EATL). Recently established treatment options also include high-dose chemotherapeutic regimens for RCD type II which have significantly improved survival. However, treatment strategies are highly individual targeting also complications of malabsorption and should be started in the RCD phase of the disease. Therefore, adequate diagnostics are pivotal for patient outcome.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc15025257
003      
CZ-PrNML
005      
20151115003718.0
007      
ta
008      
150723s2014 xxuad f 000 0|eng||
009      
AR
024    7_
$a 10.12691/ijcd-2-1-10 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Michael Schumann, $u Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité, Campus Benjamin Franklin, Berlin, Germany
245    10
$a Refractory celiac disease new diagnostic approaches and current treatment / $c Michael Schumann, Christian Bojarski, Verena Moos, Severin Daum
504    __
$a Literatura
520    9_
$a Since refractory celiac disease (RCD) may cause severe complications and is associated with a poor prognosis in a portion of patients, early diagnosis and treatment is of importance. Current diagnostics include complex PCR-based molecular pathology and FACS techniques in order to differentiate type I and type II RCD, the latter being associated with the development of an enteropathy-associated T cell lymphoma (EATL). Recently established treatment options also include high-dose chemotherapeutic regimens for RCD type II which have significantly improved survival. However, treatment strategies are highly individual targeting also complications of malabsorption and should be started in the RCD phase of the disease. Therefore, adequate diagnostics are pivotal for patient outcome.
650    12
$a celiakie $x diagnóza $x farmakoterapie $x komplikace $x patofyziologie $x prevence a kontrola $7 D002446
650    _2
$a prognóza $7 D011379
650    12
$a časná diagnóza $7 D042241
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a časná lékařská intervence $7 D061345
650    _2
$a histologie $7 D006653
650    _2
$a atrofie $7 D001284
650    _2
$a imunohistochemie $x metody $x využití $7 D007150
650    _2
$a sérologie $x metody $7 D012699
650    12
$a bezlepková dieta $x využití $7 D055050
650    12
$a imunosupresivní léčba $x využití $7 D007165
650    _2
$a budesonid $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D019819
650    _2
$a azathioprin $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D001379
650    _2
$a mesalamin $x terapeutické užití $7 D019804
650    _2
$a thioguanin $x terapeutické užití $7 D013866
650    _2
$a melfalan $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D008558
650    _2
$a lidé $7 D006801
650    _2
$a kladribin $7 D017338
653    00
$a refrakterní celiakie
653    00
$a RCD typu I
653    00
$a RCD typu II
653    00
$a protilátka infliximab TNF-a
653    00
$a tacrolimusexist
653    00
$a fludarabin
653    00
$a protilátky interleukinu - 15
700    1_
$a Christian Bojarski, $u Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité, Campus Benjamin Franklin, Berlin, Germany
700    1_
$a Verena Moos, $u Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité, Campus Benjamin Franklin, Berlin, Germany
700    1_
$a Severin Daum $u Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité, Campus Benjamin Franklin, Berlin, Germany
773    0_
$t International journal of celiac disease $x 2334-3427 $g Roč. 2, č. 1 (2014), s. 33-37 $w MED00186448
856    41
$u http://www.sciepub.com/journal/index.aspx?id=ijcd $y domovská stránka časopisu
910    __
$a ABA008 $b B 2748 $c 280 $y 4 $z 0
990    __
$a 20150723102837 $b ABA008
991    __
$a 20151115003737 $b ABA008
999    __
$a ok $b bmc $g 1085485 $s 908263
BAS    __
$a 3
BMC    __
$a 2014 $b 2 $c 1 $d 33-37 $i 2334-3427 $m International journal of celiac disease $x MED00186448
LZP    __
$c NLK185 $d 20151114 $a NLK 2015-19/mk
Back

Find record

Citation metrics

Archiving options